Today: 21 May 2026
Arm stock slips after Friday chip selloff; CEO share-sale notice puts earnings in focus

Arm stock slips after Friday chip selloff; CEO share-sale notice puts earnings in focus

New York, Jan 31, 2026, 18:24 ET — The market has closed.

  • Arm’s U.S.-listed sponsored ADRs dropped 2.8% in the last session, mirroring a wider slump across chip stocks.
  • CEO Rene Haas filed a Form 144 revealing his intent to sell 6,152 American depositary shares.
  • The company will release its fiscal third-quarter results on Feb. 4.

Arm’s U.S.-listed sponsored ADRs closed Friday down 2.8%, hitting $105.36. During the session, the shares swung between $105.05 and $108.00, according to market data.

The drop carries extra weight heading into next week as rates and tech shift in sync again, following Donald Trump’s choice of Kevin Warsh to replace Jerome Powell at the Federal Reserve, investors noted. “Markets are calibrating to Trump’s pick of Kevin Warsh … and the outlook for monetary policy,” said Michael Hans, chief investment officer at Citizens Wealth. Reuters

Chip stocks came under heavy pressure during the wider selloff, with major semiconductor and AI-related names dropping sharply, according to a market summary on Nasdaq.com. The 10-year Treasury yield rose, while investors flagged hotter-than-expected producer-price inflation as a further drag on high-valuation growth shares.

Separately, a Form 144 filing revealed that Arm CEO Rene Haas intends to offload 6,152 American depositary shares via Fidelity Brokerage Services LLC around Jan. 30. The total value of the sale is estimated at roughly $654,000.

Form 144 serves as a notice under SEC Rule 144, which regulates the resale of restricted securities. It signals a planned sale but doesn’t confirm that the shares will actually be sold.

Arm is set to release its fiscal third-quarter earnings on Wednesday, Feb. 4, after the market closes. The company will hold a conference call at 5 p.m. ET.

Investors are focused on the pace of royalty growth as newer Arm-based chips hit the market, while watching licensing demand for mobile and data-center designs as customers juggle budgets. A shift in pricing power or deal timing could send this stock moving sharply.

The setup works both ways. If yields keep climbing or chip stocks remain weak, even a strong quarter might get overshadowed by broader market moves. Conversely, a cautious outlook would probably hit harder, given that semiconductor valuations are still in flux.

Trading will pick back up Monday following the weekend pause, with Arm’s Feb. 4 earnings report and forecast standing out as the next major catalyst.

Stock Market Today

  • EnerSys Q1 CY2026 Sales Beat Estimates with Optimistic Guidance
    May 20, 2026, 6:18 PM EDT. Battery maker EnerSys (NYSE:ENS) reported Q1 CY2026 sales of $988 million, up 1.4% year on year, beating analyst estimates by 1.5%. Adjusted earnings per share (EPS) stood at $3.19, a 6.6% beat over consensus. Guidance for Q2 revenue is $935 million, 2.2% above estimates, with adjusted EPS guidance also exceeding forecasts. Despite a 6% decline in sales volumes, revenue growth was supported by price increases. Free cash flow turned negative at -$12.66 million, down from $105 million last year. EnerSys continues to push its lithium data center and battery energy storage system solutions, signaling long-term innovation. The company's subdued 4.7% annualized revenue growth over five years contrasts with sector expectations, raising caution among investors.

Latest articles

AEVEX Stock Jumps After Hours as Drone Maker Posts 307% Revenue Surge and New Air Force Deal

AEVEX Stock Jumps After Hours as Drone Maker Posts 307% Revenue Surge and New Air Force Deal

21 May 2026
AEVEX Corp. shares surged over 10% after hours Wednesday following a first-quarter profit of $21 million and new U.S. Air Force contracts worth $15.6 million. Revenue jumped to $216.7 million, beating estimates. The company, which went public in April, raised its full-year revenue outlook to $600–$620 million. The stock had closed regular trading at $26.27, down 0.23%.
Jupiter Neurosciences Stock Swings on $100M MDMA Pact, $2M Equity Sale

Jupiter Neurosciences Stock Swings on $100M MDMA Pact, $2M Equity Sale

21 May 2026
Jupiter Neurosciences shares fell 37% to $0.205 Wednesday after announcing a proposed U.S. licensing deal for PharmAla Biotech’s MDMA-based ALA-002 and a $2 million stock offering. Trading volume topped 230 million shares. The licensing agreement is non-binding, with a potential value over $100 million, and gives Jupiter 90 days to finalize terms. Jupiter reported a $2.06 million Q1 net loss and $2.36 million in cash.
Urban Outfitters Stock Swings After Record Q1—What Nuuly and Tariffs Are Telling Investors

Urban Outfitters Stock Swings After Record Q1—What Nuuly and Tariffs Are Telling Investors

21 May 2026
Urban Outfitters posted record first-quarter net income of $115.7 million and sales of $1.48 billion, beating analyst estimates. Shares closed up 4.05% at $71.67 before slipping to $70.55 in after-hours trading. Comparable retail sales rose 5.6%, with strong gains at FP Group, Urban Outfitters, and Nuuly. Gross profit rate edged down to 36.6% as tariffs pressured costs.
Abbott Laboratories stock price: ABT ends Friday up 3% — what investors watch next week
Previous Story

Abbott Laboratories stock price: ABT ends Friday up 3% — what investors watch next week

Renesas stock price: Wolfspeed stake update lands days before Feb. 5 earnings
Next Story

Renesas stock price: Wolfspeed stake update lands days before Feb. 5 earnings

Go toTop